SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/253290"
 

Search: onr:"swepub:oai:gup.ub.gu.se/253290" > A Guide to Medicati...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004714naa a2200637 4500
001oai:gup.ub.gu.se/253290
003SwePub
008240528s2017 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2532902 URI
024a https://doi.org/10.1007/s40268-016-0153-92 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Wolff, A.4 aut
2451 0a A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI
264 c 2016-11-16
264 1b Springer Science and Business Media LLC,c 2017
520 a Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. Objective Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data Sources Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the abovementioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. Limitations While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search. Conclusions We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmakologi och toxikologi0 (SwePub)301022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmacology and Toxicology0 (SwePub)301022 hsv//eng
653 a major depressive disorder
653 a placebo-controlled trial
653 a generalized anxiety
653 a disorder
653 a extended-release quetiapine
653 a attention-deficit/hyperactivity
653 a disorder
653 a quality-of-life
653 a deficit hyperactivity disorder
653 a randomized
653 a controlled-trial
653 a muscarinic receptor antagonists
653 a advanced
653 a parkinsons-disease
653 a Pharmacology & Pharmacy
700a Joshi, R. K.4 aut
700a Ekström, Jörgen,d 1944u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology4 aut0 (Swepub:gu)xeksjo
700a Aframian, D.4 aut
700a Pedersen, A. M. L.4 aut
700a Proctor, G.4 aut
700a Narayana, N.4 aut
700a Villa, A.4 aut
700a Sia, Y. W.4 aut
700a Aliko, A.4 aut
700a McGowan, R.4 aut
700a Kerr, A. R.4 aut
700a Jensen, S. B.4 aut
700a Vissink, A.4 aut
700a Dawes, C.4 aut
710a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi4 org
773t Drugs in R&Dd : Springer Science and Business Media LLCg 17:1, s. 1-28q 17:1<1-28x 1174-5886x 1179-6901
856u https://link.springer.com/content/pdf/10.1007%2Fs40268-016-0153-9.pdf
8564 8u https://gup.ub.gu.se/publication/253290
8564 8u https://doi.org/10.1007/s40268-016-0153-9

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view